Fera launches Garamycin
NEW YORK Fera Pharmaceuticals has launched a preservative-free ointment for treating bacterial infections of the eye, the company said Monday.
Fera said the launch of Garamycin (gentamicin sulfate) was to meet an unmet need for a preservative-free version of the drug. The Food and Drug Administration had received reports of allergic reactions in infants who had received formulations of the drug with preservatives.
“Garamycin is a brand name physicians have relied on for years to treat various ocular bacterial infections,” Fera VP sales Craig Salmon said. “So when we had the opportunity to bring this trusted brand back, we did.”